Zimmer Biomet Holdings, Inc. (SIX: ZBH.SW) Stock Competitors & Peer Comparison
See ZBH.SW's competitors and their performance on the SIX and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ZBH.SW and its SIX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZBH.SW | CHF 75.00 | -3.23% | 14.5B | 12.13 | CHF 6.19 | +1.04% |
| ABT.SW | CHF 72.50 | -2.68% | 125.5B | 19.79 | CHF 3.66 | +2.78% |
| SOON.SW | CHF 279.80 | +0.43% | 16.4B | 30.42 | CHF 9.10 | +1.70% |
| MED.SW | CHF 90.20 | +2.85% | 1.1B | 75.08 | CHF 1.20 | N/A |
| KURN.SW | CHF 19.74 | +5.39% | 771.2M | 107.40 | CHF 0.18 | N/A |
| METN.SW | CHF 845.00 | -0.24% | 381.7M | -35.41 | -CHF 24.06 | N/A |
| SHLTN.SW | CHF 1.07 | +3.38% | 39.7M | -0.62 | -CHF 1.71 | N/A |
Stock Comparison
Abbott Laboratories (SIX: ABT.SW)
ZBH.SW vs ABT.SW Comparison October 2026
Zimmer Biomet Holdings, Inc. (SIX: ZBH.SW) plays a significant role within the Healthcare sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZBH.SW stands at 14.5B. In comparison, ABT.SW has a market cap of 125.5B. Regarding current trading prices, ZBH.SW is priced at CHF 75.00 on the SIX, while ABT.SW trades at CHF 72.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZBH.SW currently has a P/E ratio of 12.13, whereas ABT.SW's P/E ratio is 19.79. In terms of profitability, ZBH.SW's ROE is +0.06%, compared to ABT.SW's ROE of +0.11%. Regarding short-term risk, ZBH.SW is similarly volatile compared to ABT.SW. This indicates similar risk in terms of short-term price fluctuations for ZBH.SW.Check ABT.SW's competition here